News for uniQure N.V. (QURE)

~ Announced alignment with the U.S. Food and Drug Administration (FDA) on key elements of the Accelerated Approval pathway for AMT-130 in Huntington's disease;

**media[552098]**

uniQure's stock rises on Huntington's therapy progress and strong gene therapy pipeline. Learn about QURE stock's cost-cutting measures and analyst support.

uniQure's AMT-130 shows 80% Huntington's progress reduction, eyeing FDA approval. Click here to read why I rate QURE stock a Buy.

PR NewswireKING OF PRUSSIA, Pa., Feb. 7, 2025 94 percent of patients eliminated factor IX prophylaxis and remained free of continuous prophylaxis through f

**media[528038]**

One of the strongest stock market anomalies is the momentum effect, which is the tendency of recent past winners to outperform the recent past losers.

We recently compiled a list of the 12 Best Growth Stocks to Buy and Hold in 2025. In this article, we are going to take a look at where uniQure N.V.

uniQure N.V. (QURE), Wednesday announced the pricing of underwritten public offering of around 4.4 million shares at $17 per share, raising a total of nearly $75 million.

**media[508723]**

uniQure (QURE) has filed for a mixed securities shelf offering, signaling potential changes in the company's financial strategy.

LEXINGTON, Mass. and AMSTERDAM, Jan. 07, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced

Uniqure stock soars to 52-week high, reaches $18.14

uniQure CFO Christian Klemt sells $13,559 in stock

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.35%

Published Dec 10, 2024 02:02PM ET © Reuters. "Oracle, MongoDB (NASDAQ: ) Dive; Tesla, Google Rally Among Tuesday's Market Cap Stock Movers" Article Content:...

U.S. stocks traded mixed toward the end of trading, with the S&P 500 falling by around 0.1% on Tuesday. The Dow traded down 0.02% to 44,393.25 while the NASDAQ...

U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining around 50 points on Tuesday. The Dow traded up 0.02% to 44,412.05 wh...

U.S. stocks were mixed, with the Nasdaq Composite gaining around 100 points on Tuesday. Shares of United Natural Foods, Inc. UNFI rose sharply during Tuesday's...